Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04303676 · ClinicalTrials.gov registry record · NA
Facilitating Alcohol Screening and Treatment (FAST)
A NA study of Alcohol Use Disorder, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 399
- Enrollment target
- 1
- Study location
NCT04303676: Completed NA study of Alcohol Use Disorder, sponsored by University of Colorado, Denver.
NCT04303676 is a NA study of Alcohol Use Disorder that has completed, run by University of Colorado, Denver. The registered enrollment target is 399 participants, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04303676, a NA study of Alcohol Use Disorder, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 399 participants
- Enrollment target
- 1
- Study location
Study Summary
Alcohol use is the third leading cause of death in the United States. Primary care practices need to implement new research findings that help identify and treat alcohol use disorder. This project will compare two methods of supporting small and medium size primary care practices in Colorado and surrounding states to improve their alcohol screening and treatment.
Primary Outcome
Change from baseline in number and percent of eligible patients (18 years old or older) screened for unhealthy alcohol use. Change will be assessed at 3, 6, and 9 months from baseline.
Conditions Studied
Interventions
- OTHER Virtual Practice Facilitation with e-Learning
- OTHER Virtual Practice Facilitation without e-Learning
Study Locations (1)
Colorado
- University of Colorado at Denver and Health Sciences Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2020-05-26 |
| Est. Completion | 2023-04-13 |
| Phase | NA |
What the finished NCT04303676 record still lists
NCT04303676 is an interventional study that assigns participants to a tested intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (22% higher).
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Virtual Practice Facilitation with e-Learning is the first listed.
NCT04303676 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04303676 about?
NCT04303676 is a clinical study titled "Facilitating Alcohol Screening and Treatment (FAST)". Alcohol use is the third leading cause of death in the United States. Primary care practices need to implement new research findings that help identify and treat alcohol use disorder. This project will compare two methods of supporting small and medium size primary care practices in Colorado and sur...
What is the current status of trial NCT04303676?
This trial is currently completed. It is a NA study. The enrollment target is 399 participants. The study started on 2020-05-26. Estimated completion is 2023-04-13.
What conditions does trial NCT04303676 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT04303676?
The interventions under investigation include: Virtual Practice Facilitation with e-Learning (OTHER), Virtual Practice Facilitation without e-Learning (OTHER).
Who is sponsoring clinical trial NCT04303676?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04303676 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04303676's enrollment target sits among peer trials
399 23rd of 184 higher than 162 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI